Loading…
Cyclic Dodecapeptide Induces Cell Death Through Membrane–Peptide Interactions in Breast Cancer Cells
Antimicrobial peptides (AMPs) are present in many organisms ranging from insects to mammals. They have a selectivity as cationic and amphiphilic α-helical peptide molecules and might interact with tumor cell membranes. In this study, it was aimed to investigate the anticancer effects of cyclic dodec...
Saved in:
Published in: | International journal of peptide research and therapeutics 2022-03, Vol.28 (2), Article 67 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c319t-ab89b3b900280318b1a753567aa81be735af781561d8da1b5809556353afbd413 |
---|---|
cites | cdi_FETCH-LOGICAL-c319t-ab89b3b900280318b1a753567aa81be735af781561d8da1b5809556353afbd413 |
container_end_page | |
container_issue | 2 |
container_start_page | |
container_title | International journal of peptide research and therapeutics |
container_volume | 28 |
creator | Sancar, Serap Bolkent, Sehnaz |
description | Antimicrobial peptides (AMPs) are present in many organisms ranging from insects to mammals. They have a selectivity as cationic and amphiphilic α-helical peptide molecules and might interact with tumor cell membranes. In this study, it was aimed to investigate the anticancer effects of cyclic dodecapeptide (CDP), which is an AMP on MCF-7 and MDA-MB 231 cells from breast cancer cell lines for the first time. Anticancer activity and mechanism of action of CDP were investigated via cancer cell viability assay, cell cytotoxic assay, acridine orange/ethidium bromide dual fluorescence dying assay and scanning electron microscope technique, solid phase heparan sulfate and chondroitin sulfate binding assay, and peptide binding assay. CDP decreases cell viability and induces the death of breast cancer cells by impairing the membrane integrity and causes necrotic cell death by forming pores in the membranes. CDP binds to the negatively charged glycosaminoglycans and shows more affinity against breast cancer cells than fibroblast cells. As a result, the anticancer activity of CDP presented for the first time against breast cancer cells and it has a therapeutic value due to its selective toxicity.
Graphical Abstract |
doi_str_mv | 10.1007/s10989-022-10369-2 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2627006932</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2627006932</sourcerecordid><originalsourceid>FETCH-LOGICAL-c319t-ab89b3b900280318b1a753567aa81be735af781561d8da1b5809556353afbd413</originalsourceid><addsrcrecordid>eNp9kL1OwzAUhS0EEqXwAkyWmAPXdh3bI6T8VCqCocyW7ThtqjQpdjKw8Q68IU9C2vCzMd0zfOdc6UPonMAlARBXkYCSKgFKEwIsVQk9QCPCBUuYgsnhTyYTdYxOYlwDcCoIjFCRvbmqdHja5N6Zrd-2Ze7xrM475yPOfFXhqTftCi9WoemWK_zoNzaY2n--fzz_0q0PxrVlU0dc1vgmeBNbnJna-bDfiKfoqDBV9Gffd4xe7m4X2UMyf7qfZdfzxDGi2sRYqSyzCoBKYERaYgRnPBXGSGK9YNwUQhKeklzmhlguQXGeMs5MYfMJYWN0MexuQ_Pa-djqddOFun-paUoFQKoY7Sk6UC40MQZf6G0oNya8aQJ651MPPnXvU-996l2JDaXYw_XSh7_pf1pfswR4jQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2627006932</pqid></control><display><type>article</type><title>Cyclic Dodecapeptide Induces Cell Death Through Membrane–Peptide Interactions in Breast Cancer Cells</title><source>Springer Link</source><creator>Sancar, Serap ; Bolkent, Sehnaz</creator><creatorcontrib>Sancar, Serap ; Bolkent, Sehnaz</creatorcontrib><description>Antimicrobial peptides (AMPs) are present in many organisms ranging from insects to mammals. They have a selectivity as cationic and amphiphilic α-helical peptide molecules and might interact with tumor cell membranes. In this study, it was aimed to investigate the anticancer effects of cyclic dodecapeptide (CDP), which is an AMP on MCF-7 and MDA-MB 231 cells from breast cancer cell lines for the first time. Anticancer activity and mechanism of action of CDP were investigated via cancer cell viability assay, cell cytotoxic assay, acridine orange/ethidium bromide dual fluorescence dying assay and scanning electron microscope technique, solid phase heparan sulfate and chondroitin sulfate binding assay, and peptide binding assay. CDP decreases cell viability and induces the death of breast cancer cells by impairing the membrane integrity and causes necrotic cell death by forming pores in the membranes. CDP binds to the negatively charged glycosaminoglycans and shows more affinity against breast cancer cells than fibroblast cells. As a result, the anticancer activity of CDP presented for the first time against breast cancer cells and it has a therapeutic value due to its selective toxicity.
Graphical Abstract</description><identifier>ISSN: 1573-3149</identifier><identifier>EISSN: 1573-3904</identifier><identifier>DOI: 10.1007/s10989-022-10369-2</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Acridine orange ; Animal Anatomy ; Antimicrobial agents ; Antimicrobial peptides ; Antitumor activity ; Apoptosis ; Biochemistry ; Biomedical and Life Sciences ; Breast cancer ; Cell death ; Cell membranes ; Cell viability ; Chondroitin sulfate ; Cytotoxicity ; Ethidium bromide ; Glycosaminoglycans ; Heparan sulfate ; Histology ; Life Sciences ; Molecular Medicine ; Morphology ; Peptides ; Pharmaceutical Sciences/Technology ; Pharmacology/Toxicology ; Polymer Sciences ; Scanning electron microscopy ; Tumor cell lines ; Tumors</subject><ispartof>International journal of peptide research and therapeutics, 2022-03, Vol.28 (2), Article 67</ispartof><rights>The Author(s), under exclusive licence to Springer Nature B.V. 2022</rights><rights>The Author(s), under exclusive licence to Springer Nature B.V. 2022.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c319t-ab89b3b900280318b1a753567aa81be735af781561d8da1b5809556353afbd413</citedby><cites>FETCH-LOGICAL-c319t-ab89b3b900280318b1a753567aa81be735af781561d8da1b5809556353afbd413</cites><orcidid>0000-0002-7093-4744</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Sancar, Serap</creatorcontrib><creatorcontrib>Bolkent, Sehnaz</creatorcontrib><title>Cyclic Dodecapeptide Induces Cell Death Through Membrane–Peptide Interactions in Breast Cancer Cells</title><title>International journal of peptide research and therapeutics</title><addtitle>Int J Pept Res Ther</addtitle><description>Antimicrobial peptides (AMPs) are present in many organisms ranging from insects to mammals. They have a selectivity as cationic and amphiphilic α-helical peptide molecules and might interact with tumor cell membranes. In this study, it was aimed to investigate the anticancer effects of cyclic dodecapeptide (CDP), which is an AMP on MCF-7 and MDA-MB 231 cells from breast cancer cell lines for the first time. Anticancer activity and mechanism of action of CDP were investigated via cancer cell viability assay, cell cytotoxic assay, acridine orange/ethidium bromide dual fluorescence dying assay and scanning electron microscope technique, solid phase heparan sulfate and chondroitin sulfate binding assay, and peptide binding assay. CDP decreases cell viability and induces the death of breast cancer cells by impairing the membrane integrity and causes necrotic cell death by forming pores in the membranes. CDP binds to the negatively charged glycosaminoglycans and shows more affinity against breast cancer cells than fibroblast cells. As a result, the anticancer activity of CDP presented for the first time against breast cancer cells and it has a therapeutic value due to its selective toxicity.
Graphical Abstract</description><subject>Acridine orange</subject><subject>Animal Anatomy</subject><subject>Antimicrobial agents</subject><subject>Antimicrobial peptides</subject><subject>Antitumor activity</subject><subject>Apoptosis</subject><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>Breast cancer</subject><subject>Cell death</subject><subject>Cell membranes</subject><subject>Cell viability</subject><subject>Chondroitin sulfate</subject><subject>Cytotoxicity</subject><subject>Ethidium bromide</subject><subject>Glycosaminoglycans</subject><subject>Heparan sulfate</subject><subject>Histology</subject><subject>Life Sciences</subject><subject>Molecular Medicine</subject><subject>Morphology</subject><subject>Peptides</subject><subject>Pharmaceutical Sciences/Technology</subject><subject>Pharmacology/Toxicology</subject><subject>Polymer Sciences</subject><subject>Scanning electron microscopy</subject><subject>Tumor cell lines</subject><subject>Tumors</subject><issn>1573-3149</issn><issn>1573-3904</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kL1OwzAUhS0EEqXwAkyWmAPXdh3bI6T8VCqCocyW7ThtqjQpdjKw8Q68IU9C2vCzMd0zfOdc6UPonMAlARBXkYCSKgFKEwIsVQk9QCPCBUuYgsnhTyYTdYxOYlwDcCoIjFCRvbmqdHja5N6Zrd-2Ze7xrM475yPOfFXhqTftCi9WoemWK_zoNzaY2n--fzz_0q0PxrVlU0dc1vgmeBNbnJna-bDfiKfoqDBV9Gffd4xe7m4X2UMyf7qfZdfzxDGi2sRYqSyzCoBKYERaYgRnPBXGSGK9YNwUQhKeklzmhlguQXGeMs5MYfMJYWN0MexuQ_Pa-djqddOFun-paUoFQKoY7Sk6UC40MQZf6G0oNya8aQJ651MPPnXvU-996l2JDaXYw_XSh7_pf1pfswR4jQ</recordid><startdate>20220301</startdate><enddate>20220301</enddate><creator>Sancar, Serap</creator><creator>Bolkent, Sehnaz</creator><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88I</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><orcidid>https://orcid.org/0000-0002-7093-4744</orcidid></search><sort><creationdate>20220301</creationdate><title>Cyclic Dodecapeptide Induces Cell Death Through Membrane–Peptide Interactions in Breast Cancer Cells</title><author>Sancar, Serap ; Bolkent, Sehnaz</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c319t-ab89b3b900280318b1a753567aa81be735af781561d8da1b5809556353afbd413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Acridine orange</topic><topic>Animal Anatomy</topic><topic>Antimicrobial agents</topic><topic>Antimicrobial peptides</topic><topic>Antitumor activity</topic><topic>Apoptosis</topic><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>Breast cancer</topic><topic>Cell death</topic><topic>Cell membranes</topic><topic>Cell viability</topic><topic>Chondroitin sulfate</topic><topic>Cytotoxicity</topic><topic>Ethidium bromide</topic><topic>Glycosaminoglycans</topic><topic>Heparan sulfate</topic><topic>Histology</topic><topic>Life Sciences</topic><topic>Molecular Medicine</topic><topic>Morphology</topic><topic>Peptides</topic><topic>Pharmaceutical Sciences/Technology</topic><topic>Pharmacology/Toxicology</topic><topic>Polymer Sciences</topic><topic>Scanning electron microscopy</topic><topic>Tumor cell lines</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sancar, Serap</creatorcontrib><creatorcontrib>Bolkent, Sehnaz</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest_Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest Science Journals</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>International journal of peptide research and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sancar, Serap</au><au>Bolkent, Sehnaz</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cyclic Dodecapeptide Induces Cell Death Through Membrane–Peptide Interactions in Breast Cancer Cells</atitle><jtitle>International journal of peptide research and therapeutics</jtitle><stitle>Int J Pept Res Ther</stitle><date>2022-03-01</date><risdate>2022</risdate><volume>28</volume><issue>2</issue><artnum>67</artnum><issn>1573-3149</issn><eissn>1573-3904</eissn><abstract>Antimicrobial peptides (AMPs) are present in many organisms ranging from insects to mammals. They have a selectivity as cationic and amphiphilic α-helical peptide molecules and might interact with tumor cell membranes. In this study, it was aimed to investigate the anticancer effects of cyclic dodecapeptide (CDP), which is an AMP on MCF-7 and MDA-MB 231 cells from breast cancer cell lines for the first time. Anticancer activity and mechanism of action of CDP were investigated via cancer cell viability assay, cell cytotoxic assay, acridine orange/ethidium bromide dual fluorescence dying assay and scanning electron microscope technique, solid phase heparan sulfate and chondroitin sulfate binding assay, and peptide binding assay. CDP decreases cell viability and induces the death of breast cancer cells by impairing the membrane integrity and causes necrotic cell death by forming pores in the membranes. CDP binds to the negatively charged glycosaminoglycans and shows more affinity against breast cancer cells than fibroblast cells. As a result, the anticancer activity of CDP presented for the first time against breast cancer cells and it has a therapeutic value due to its selective toxicity.
Graphical Abstract</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><doi>10.1007/s10989-022-10369-2</doi><orcidid>https://orcid.org/0000-0002-7093-4744</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1573-3149 |
ispartof | International journal of peptide research and therapeutics, 2022-03, Vol.28 (2), Article 67 |
issn | 1573-3149 1573-3904 |
language | eng |
recordid | cdi_proquest_journals_2627006932 |
source | Springer Link |
subjects | Acridine orange Animal Anatomy Antimicrobial agents Antimicrobial peptides Antitumor activity Apoptosis Biochemistry Biomedical and Life Sciences Breast cancer Cell death Cell membranes Cell viability Chondroitin sulfate Cytotoxicity Ethidium bromide Glycosaminoglycans Heparan sulfate Histology Life Sciences Molecular Medicine Morphology Peptides Pharmaceutical Sciences/Technology Pharmacology/Toxicology Polymer Sciences Scanning electron microscopy Tumor cell lines Tumors |
title | Cyclic Dodecapeptide Induces Cell Death Through Membrane–Peptide Interactions in Breast Cancer Cells |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T13%3A11%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cyclic%20Dodecapeptide%20Induces%20Cell%20Death%20Through%20Membrane%E2%80%93Peptide%20Interactions%20in%20Breast%20Cancer%20Cells&rft.jtitle=International%20journal%20of%20peptide%20research%20and%20therapeutics&rft.au=Sancar,%20Serap&rft.date=2022-03-01&rft.volume=28&rft.issue=2&rft.artnum=67&rft.issn=1573-3149&rft.eissn=1573-3904&rft_id=info:doi/10.1007/s10989-022-10369-2&rft_dat=%3Cproquest_cross%3E2627006932%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c319t-ab89b3b900280318b1a753567aa81be735af781561d8da1b5809556353afbd413%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2627006932&rft_id=info:pmid/&rfr_iscdi=true |